Drug Type Small molecule drug |
Synonyms ATPace |
Target |
Action agonists |
Mechanism Purinergic P2 receptor agonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H16N5O13P3 |
InChIKeyZKHQWZAMYRWXGA-KQYNXXCUSA-N |
CAS Registry56-65-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bradycardia | Phase 3 | - | - | |
Bradycardia | Phase 3 | Canada | - | |
Bradycardia | Phase 3 | - | - | |
Bradycardia | Phase 3 | - | - | |
Bradycardia | Phase 3 | - | - | |
Bradycardia | Phase 3 | Canada | - | |
Tachycardia | Phase 3 | - | - | |
Tachycardia | Phase 3 | - | - | |
Tachycardia | Phase 3 | - | - | |
Tachycardia | Phase 3 | - | - |
Not Applicable | 58 | (Chronic Cough Participant) | jitqivllil(zhkbomkgui) = bhcpbrgjqk qkeyminvak (memtcgkwyd, rtptijjacu - jjzrpewwew) View more | - | 22 Aug 2024 | ||
(Healthy Control Participant) | jitqivllil(zhkbomkgui) = ookqsriinm qkeyminvak (memtcgkwyd, mopcajwrzc - idkztmehfi) View more |